Fierce Biotech

Staar Surgical's takeover saga ends as shareholder revolt stops Alcon’s attempted merger deal

Staar Surgical will remain independent after a bitter shareholder battle that has raged for the past several months has now ...
Business Wire

Leading Independent Proxy Advisory Firm ISS Recommends STAAR Stockholders Vote “FOR” Alcon Merger

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses (EVO ICL™) for vision ...
Morning Sun

Leading Independent Proxy Advisory Firm ISS Recommends STAAR Stockholders Vote “FOR” Alcon Merger

LAKE FOREST, Calif.--(BUSINESS WIRE)--Dec 15, 2025--STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), the global leader in phakic IOLs with the EVO family of Implantable Collamer ® Lenses (EVO … This ...
Seeking Alpha

Alcon draws double downgrade at BofA on earnings growth risk

Alcon (ALC) received its lone sell-equivalent rating on Wall Street as Bank of America downgraded the Swiss eye care company to Underperform from Buy on Thursday, arguing that consensus estimates are ...
Seeking Alpha

STAAR Surgical: Alcon Raises Its Bid, But Obstacles Remain

Alcon has raised its offer to acquire STAA by 10% to $30.75 per share. STAA's major shareholder, with a 30% stake, intends to vote against the acquisition, stating that the price still significantly ...
Business Wire

Yunqi Capital Comments on STAAR Surgical’s Go-Shop Process and Alcon’s Revised Offer

We are writing to share with you our continued opposition to the proposed transaction. After reviewing the announcements by STAAR and Alcon regarding the course and closing of the 30-day go-shop ...
Reuters

Swiss eyecare giant Alcon lifts bid for rival Staar

Dec 9 (Reuters) - Swiss eyecare giant Alcon (ALCC.S), opens new tab has made a new offer for Staar Surgical (STAA.O), opens new tab worth $1.6 billion, it said on Tuesday, as it seeks to clinch a deal ...